Effects of dipeptidyl peptidase-4 inhibitor sitagliptin on coronary atherosclerosis as assessed by intravascular ultrasound in type 2 diabetes mellitus with coronary artery disease

Conclusions The addition of sitagliptin to statins did not cause coronary plaque regression in T2DM with CAD. Graphical abstract
Source: IJC Metabolic and Endocrine - Category: Endocrinology Source Type: research